N@N

Bill Sutherland Upgraded (AMED) to Strong Buy and Held Target at $205 on, Mar 9th, 2020

Bill Sutherland of Benchmark, Upgraded "Amedisys, Inc." (AMED) to Strong Buy and Held Target at $205 on, Mar 9th, 2020.

Bill has made no other calls on AMED in the last 4 months.

There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 3 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Andrew Mok of "UBS" Maintained at Hold with Increased Target to $208 on, Friday, February 21st, 2020
• Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $200 on, Friday, February 21st, 2020
• Matt Borsch of "BMO Capital" Initiated at Hold and Held Target at $170 on, Friday, December 6th, 2019

These are the ratings of the 3 analyists that currently disagree with Bill

---

• John Ransom of "Raymond James" Maintained at Buy with Increased Target to $225 on, Thursday, February 20th, 2020
• A.J. Rice of "Credit Suisse" Initiated at Buy and Held Target at $206 on, Friday, January 17th, 2020
• Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $178 on, Tuesday, November 26th, 2019

Contributing Sources

---